More Information Internet Security Policyīy using this site, you are agreeing to security monitoring and auditing. For more information, contact more information, please see the SEC’s Web Site Privacy and Security Policy.
QUEST DIAGNOSTICS LOCATIONS DOWNLOAD
You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. Please declare your traffic by updating your user agent to include company specific information.įor best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. Your request has been identified as part of a network of automated tools outside of the acceptable policy and will be managed until action is taken to declare your traffic. To allow for equitable access to all users, SEC reserves the right to limit requests originating from undeclared automated tools. Key Mergers And Acquisitions In The Drug Screening MarketĢ9.Your Request Originates from an Undeclared Automated Tool Drug Screening Market Competitive Landscape And Company ProfilesĢ8. Drug Screening Market Regional And Country AnalysisĢ7. Drug Screening Market Trends And Strategiesħ.
This test is only for use in criminal justice and forensics.ġ) By Products: Rapid Testing Devices Consumables OthersĢ) By Sample Type: Oral Fluid Sample Hair Sample Urine Sample Breath Sample Othersģ) By End User: Drug Testing Laboratories Workplaces Criminal Justice and Law Enforcement Agencies Hospitals Drug Treatment Centers Individual Users Pain Management Centers Schools and Collegesģ. Named CEDIA Mitragynine (Kratom) Assay, it can be performed on widely used clinical chemistry analyzers, allowing a wide range of laboratories to test for the presence of Kratom. For instance, in April 2019, Thermo Fisher Scientific, a US-based laboratory supply and biotechnology company introduced a new drug of abuse test with supporting calibrators and controls. Additionally, due to COVID, there was a sudden change in the drug screening approach, which changed the screening methodologies and pushed the innovation and new product development by companies.Ĭompanies are striving to develop new products such as a new drug test that is more effective and can be widely used by laboratories. Major companies operating in the drug screening market are focusing on providing innovative products to meet fast-growing industry demand and strengthen their market position. The development of innovative products is a key trend gaining popularity in the drug screening market. Therefore, growing drug and alcohol consumption is driving the growth of the drug screening market. The pandemic effects also ramp up drug risks, as cannabis intake by youth had increased by as much as four times in parts of the world. The severity and complexity of the world drug situation are increasing, revealing that the number of people who use drugs is now 30% higher than in 2009. As the drug and alcohol addiction increases, the chances of disease are higher which triggers the need for drug screening.įor instance, in June 2019 & 2020, according to a report published by the United Nations Office on Drugs and Crime (UNODC), 35 million people globally suffer from drug use disorders and require treatment services. Substances such as alcohol, marijuana, and nicotine also are considered drugs. Drug addiction is a disease that affects a person's brain and behavior, resulting in the inability to control the use of a legal or illegal drug or medication. Growing drug and alcohol consumption is driving the growth of the drug screening market. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Asia-Pacific is expected to be the fastest-growing region in the forecast period. North America was the largest region in the drug screening market in 2021. The drug screening market is expected to grow to $10.66 billion in 2026 at a compound annual growth rate (CAGR) of 12.81%. The global drug screening market is expected to grow from $5.80 billion in 2021 to $6.58 billion in 2022 at a compound annual growth rate (CAGR) of 13.53%. 23, 2022 (GLOBE NEWSWIRE) - The "Drug Screening Global Market Report 2022" report has been added to 's offering.
0 kommentar(er)
